nodes	percent_of_prediction	percent_of_DWPC	metapath
Mechlorethamine—Agranulocytosis—Vinblastine—kidney cancer	0.00381	0.00383	CcSEcCtD
Mechlorethamine—Cyclophosphamide—ABCB1—kidney cancer	0.00378	1	CrCbGaD
Mechlorethamine—Dermatitis bullous—Gemcitabine—kidney cancer	0.00371	0.00372	CcSEcCtD
Mechlorethamine—Haemoglobin—Vinblastine—kidney cancer	0.00369	0.0037	CcSEcCtD
Mechlorethamine—Haemoglobin—Everolimus—kidney cancer	0.00367	0.00369	CcSEcCtD
Mechlorethamine—Haemorrhage—Vinblastine—kidney cancer	0.00367	0.00368	CcSEcCtD
Mechlorethamine—Haemorrhage—Everolimus—kidney cancer	0.00366	0.00367	CcSEcCtD
Mechlorethamine—Skin hyperpigmentation—Doxorubicin—kidney cancer	0.00363	0.00365	CcSEcCtD
Mechlorethamine—Pancytopenia—Sunitinib—kidney cancer	0.00362	0.00364	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Temsirolimus—kidney cancer	0.00362	0.00363	CcSEcCtD
Mechlorethamine—Leukopenia—Pazopanib—kidney cancer	0.00361	0.00362	CcSEcCtD
Mechlorethamine—Haemoglobin—Erlotinib—kidney cancer	0.00355	0.00356	CcSEcCtD
Mechlorethamine—Haemorrhage—Erlotinib—kidney cancer	0.00353	0.00354	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Temsirolimus—kidney cancer	0.00349	0.0035	CcSEcCtD
Mechlorethamine—Infection—Temsirolimus—kidney cancer	0.00347	0.00348	CcSEcCtD
Mechlorethamine—Jaundice—Sorafenib—kidney cancer	0.00345	0.00346	CcSEcCtD
Mechlorethamine—Pancytopenia—Dactinomycin—kidney cancer	0.00343	0.00344	CcSEcCtD
Mechlorethamine—Thrombophlebitis—Paclitaxel—kidney cancer	0.00343	0.00344	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Temsirolimus—kidney cancer	0.00342	0.00343	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Pazopanib—kidney cancer	0.00341	0.00342	CcSEcCtD
Mechlorethamine—Depression—Sunitinib—kidney cancer	0.00339	0.0034	CcSEcCtD
Mechlorethamine—Skin disorder—Temsirolimus—kidney cancer	0.00339	0.0034	CcSEcCtD
Mechlorethamine—Erythema multiforme—Erlotinib—kidney cancer	0.00334	0.00335	CcSEcCtD
Mechlorethamine—Anorexia—Temsirolimus—kidney cancer	0.00333	0.00334	CcSEcCtD
Mechlorethamine—Infection—Pazopanib—kidney cancer	0.00327	0.00328	CcSEcCtD
Mechlorethamine—Alopecia—Vinblastine—kidney cancer	0.00324	0.00326	CcSEcCtD
Mechlorethamine—Alopecia—Everolimus—kidney cancer	0.00323	0.00324	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Pazopanib—kidney cancer	0.00322	0.00323	CcSEcCtD
Mechlorethamine—Skin disorder—Pazopanib—kidney cancer	0.0032	0.00321	CcSEcCtD
Mechlorethamine—Haemoglobin—Sorafenib—kidney cancer	0.00319	0.0032	CcSEcCtD
Mechlorethamine—Haemorrhage—Sorafenib—kidney cancer	0.00317	0.00319	CcSEcCtD
Mechlorethamine—Anorexia—Pazopanib—kidney cancer	0.00314	0.00315	CcSEcCtD
Mechlorethamine—Alopecia—Erlotinib—kidney cancer	0.00312	0.00313	CcSEcCtD
Mechlorethamine—Haemoglobin—Sunitinib—kidney cancer	0.00307	0.00308	CcSEcCtD
Mechlorethamine—Pancytopenia—Vincristine—kidney cancer	0.00306	0.00308	CcSEcCtD
Mechlorethamine—Haemorrhage—Sunitinib—kidney cancer	0.00305	0.00307	CcSEcCtD
Mechlorethamine—Thrombosis—Doxorubicin—kidney cancer	0.00305	0.00306	CcSEcCtD
Mechlorethamine—Decreased appetite—Temsirolimus—kidney cancer	0.00304	0.00305	CcSEcCtD
Mechlorethamine—Agranulocytosis—Dactinomycin—kidney cancer	0.00301	0.00302	CcSEcCtD
Mechlorethamine—Erythema multiforme—Sorafenib—kidney cancer	0.003	0.00301	CcSEcCtD
Mechlorethamine—Blister—Doxorubicin—kidney cancer	0.003	0.00301	CcSEcCtD
Mechlorethamine—Tinnitus—Sorafenib—kidney cancer	0.00296	0.00297	CcSEcCtD
Mechlorethamine—Pancytopenia—Gemcitabine—kidney cancer	0.00291	0.00292	CcSEcCtD
Mechlorethamine—Erythema multiforme—Sunitinib—kidney cancer	0.00289	0.0029	CcSEcCtD
Mechlorethamine—Vertigo—Vinblastine—kidney cancer	0.00287	0.00288	CcSEcCtD
Mechlorethamine—Herpes zoster—Doxorubicin—kidney cancer	0.00287	0.00288	CcSEcCtD
Mechlorethamine—Depression—Vincristine—kidney cancer	0.00287	0.00288	CcSEcCtD
Mechlorethamine—Leukopenia—Vinblastine—kidney cancer	0.00286	0.00287	CcSEcCtD
Mechlorethamine—Decreased appetite—Pazopanib—kidney cancer	0.00286	0.00287	CcSEcCtD
Mechlorethamine—Leukopenia—Everolimus—kidney cancer	0.00285	0.00286	CcSEcCtD
Mechlorethamine—Thrombophlebitis—Capecitabine—kidney cancer	0.00281	0.00282	CcSEcCtD
Mechlorethamine—Alopecia—Sorafenib—kidney cancer	0.0028	0.00281	CcSEcCtD
Mechlorethamine—Skin ulcer—Doxorubicin—kidney cancer	0.00278	0.00279	CcSEcCtD
Mechlorethamine—Erythema multiforme—Dactinomycin—kidney cancer	0.00273	0.00274	CcSEcCtD
Mechlorethamine—Alopecia—Sunitinib—kidney cancer	0.0027	0.00271	CcSEcCtD
Mechlorethamine—Haemolytic anaemia—Capecitabine—kidney cancer	0.0027	0.00271	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.00269	0.0027	CcSEcCtD
Mechlorethamine—Petechiae—Doxorubicin—kidney cancer	0.00263	0.00264	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.0026	0.00261	CcSEcCtD
Mechlorethamine—Infection—Everolimus—kidney cancer	0.00258	0.00259	CcSEcCtD
Mechlorethamine—Hypersensitivity—Temsirolimus—kidney cancer	0.00257	0.00258	CcSEcCtD
Mechlorethamine—Alopecia—Dactinomycin—kidney cancer	0.00255	0.00256	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Vinblastine—kidney cancer	0.00255	0.00256	CcSEcCtD
Mechlorethamine—Agranulocytosis—Gemcitabine—kidney cancer	0.00255	0.00256	CcSEcCtD
Mechlorethamine—Dermatitis bullous—Capecitabine—kidney cancer	0.00255	0.00256	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Everolimus—kidney cancer	0.00254	0.00255	CcSEcCtD
Mechlorethamine—Skin disorder—Everolimus—kidney cancer	0.00252	0.00253	CcSEcCtD
Mechlorethamine—Infection—Erlotinib—kidney cancer	0.00249	0.0025	CcSEcCtD
Mechlorethamine—Anorexia—Vinblastine—kidney cancer	0.00249	0.00249	CcSEcCtD
Mechlorethamine—Anorexia—Everolimus—kidney cancer	0.00248	0.00249	CcSEcCtD
Mechlorethamine—Leukopenia—Sorafenib—kidney cancer	0.00247	0.00248	CcSEcCtD
Mechlorethamine—Pruritus—Temsirolimus—kidney cancer	0.00247	0.00248	CcSEcCtD
Mechlorethamine—Haemoglobin—Gemcitabine—kidney cancer	0.00246	0.00247	CcSEcCtD
Mechlorethamine—Amenorrhoea—Doxorubicin—kidney cancer	0.00246	0.00247	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Erlotinib—kidney cancer	0.00245	0.00246	CcSEcCtD
Mechlorethamine—Haemorrhage—Gemcitabine—kidney cancer	0.00245	0.00246	CcSEcCtD
Mechlorethamine—Skin disorder—Erlotinib—kidney cancer	0.00243	0.00244	CcSEcCtD
Mechlorethamine—Pancytopenia—Paclitaxel—kidney cancer	0.00243	0.00244	CcSEcCtD
Mechlorethamine—Diarrhoea—Temsirolimus—kidney cancer	0.00239	0.0024	CcSEcCtD
Mechlorethamine—Anorexia—Erlotinib—kidney cancer	0.00239	0.0024	CcSEcCtD
Mechlorethamine—Leukopenia—Sunitinib—kidney cancer	0.00238	0.00239	CcSEcCtD
Mechlorethamine—Oliguria—Doxorubicin—kidney cancer	0.00234	0.00235	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.00234	0.00234	CcSEcCtD
Mechlorethamine—Pruritus—Pazopanib—kidney cancer	0.00233	0.00234	CcSEcCtD
Mechlorethamine—Erythema multiforme—Gemcitabine—kidney cancer	0.00232	0.00233	CcSEcCtD
Mechlorethamine—Alopecia—Vincristine—kidney cancer	0.00228	0.00229	CcSEcCtD
Mechlorethamine—Depression—Paclitaxel—kidney cancer	0.00228	0.00229	CcSEcCtD
Mechlorethamine—Decreased appetite—Vinblastine—kidney cancer	0.00227	0.00228	CcSEcCtD
Mechlorethamine—Decreased appetite—Everolimus—kidney cancer	0.00226	0.00227	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Sorafenib—kidney cancer	0.00225	0.00226	CcSEcCtD
Mechlorethamine—Leukopenia—Dactinomycin—kidney cancer	0.00225	0.00226	CcSEcCtD
Mechlorethamine—Diarrhoea—Pazopanib—kidney cancer	0.00225	0.00226	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.00225	0.00226	CcSEcCtD
Mechlorethamine—Infection—Sorafenib—kidney cancer	0.00224	0.00225	CcSEcCtD
Mechlorethamine—Vomiting—Temsirolimus—kidney cancer	0.00222	0.00223	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Sorafenib—kidney cancer	0.00221	0.00222	CcSEcCtD
Mechlorethamine—Rash—Temsirolimus—kidney cancer	0.0022	0.00221	CcSEcCtD
Mechlorethamine—Dermatitis—Temsirolimus—kidney cancer	0.0022	0.00221	CcSEcCtD
Mechlorethamine—Skin disorder—Sorafenib—kidney cancer	0.00219	0.0022	CcSEcCtD
Mechlorethamine—Decreased appetite—Erlotinib—kidney cancer	0.00218	0.00219	CcSEcCtD
Mechlorethamine—Alopecia—Gemcitabine—kidney cancer	0.00217	0.00217	CcSEcCtD
Mechlorethamine—Infection—Sunitinib—kidney cancer	0.00216	0.00216	CcSEcCtD
Mechlorethamine—Anorexia—Sorafenib—kidney cancer	0.00215	0.00216	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Sunitinib—kidney cancer	0.00212	0.00213	CcSEcCtD
Mechlorethamine—Skin disorder—Sunitinib—kidney cancer	0.00211	0.00212	CcSEcCtD
Mechlorethamine—Vomiting—Pazopanib—kidney cancer	0.00209	0.0021	CcSEcCtD
Mechlorethamine—Rash—Pazopanib—kidney cancer	0.00207	0.00208	CcSEcCtD
Mechlorethamine—Nausea—Temsirolimus—kidney cancer	0.00207	0.00208	CcSEcCtD
Mechlorethamine—Dermatitis—Pazopanib—kidney cancer	0.00207	0.00208	CcSEcCtD
Mechlorethamine—Anorexia—Sunitinib—kidney cancer	0.00207	0.00208	CcSEcCtD
Mechlorethamine—Haemoglobin—Paclitaxel—kidney cancer	0.00206	0.00207	CcSEcCtD
Mechlorethamine—Haemorrhage—Paclitaxel—kidney cancer	0.00205	0.00206	CcSEcCtD
Mechlorethamine—Infection—Dactinomycin—kidney cancer	0.00204	0.00205	CcSEcCtD
Mechlorethamine—Vertigo—Vincristine—kidney cancer	0.00202	0.00203	CcSEcCtD
Mechlorethamine—Leukopenia—Vincristine—kidney cancer	0.00201	0.00202	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Dactinomycin—kidney cancer	0.00201	0.00202	CcSEcCtD
Mechlorethamine—Pancytopenia—Capecitabine—kidney cancer	0.002	0.002	CcSEcCtD
Mechlorethamine—Decreased appetite—Sorafenib—kidney cancer	0.00196	0.00197	CcSEcCtD
Mechlorethamine—Anorexia—Dactinomycin—kidney cancer	0.00196	0.00197	CcSEcCtD
Mechlorethamine—Nausea—Pazopanib—kidney cancer	0.00195	0.00196	CcSEcCtD
Mechlorethamine—Erythema multiforme—Paclitaxel—kidney cancer	0.00194	0.00195	CcSEcCtD
Mechlorethamine—Hypersensitivity—Vinblastine—kidney cancer	0.00192	0.00193	CcSEcCtD
Mechlorethamine—Hypersensitivity—Everolimus—kidney cancer	0.00191	0.00192	CcSEcCtD
Mechlorethamine—Tinnitus—Paclitaxel—kidney cancer	0.00191	0.00192	CcSEcCtD
Mechlorethamine—Leukopenia—Gemcitabine—kidney cancer	0.00191	0.00192	CcSEcCtD
Mechlorethamine—Decreased appetite—Sunitinib—kidney cancer	0.00189	0.00189	CcSEcCtD
Mechlorethamine—Depression—Capecitabine—kidney cancer	0.00187	0.00188	CcSEcCtD
Mechlorethamine—Pruritus—Everolimus—kidney cancer	0.00184	0.00184	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Vincristine—kidney cancer	0.00183	0.00184	CcSEcCtD
Mechlorethamine—Jaundice—Capecitabine—kidney cancer	0.00183	0.00183	CcSEcCtD
Mechlorethamine—Infection—Vincristine—kidney cancer	0.00182	0.00183	CcSEcCtD
Mechlorethamine—Alopecia—Paclitaxel—kidney cancer	0.00181	0.00182	CcSEcCtD
Mechlorethamine—Thrombophlebitis—Doxorubicin—kidney cancer	0.00181	0.00182	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.0018	0.00181	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Vincristine—kidney cancer	0.0018	0.0018	CcSEcCtD
Mechlorethamine—Decreased appetite—Dactinomycin—kidney cancer	0.00179	0.00179	CcSEcCtD
Mechlorethamine—Diarrhoea—Vinblastine—kidney cancer	0.00178	0.00179	CcSEcCtD
Mechlorethamine—Diarrhoea—Everolimus—kidney cancer	0.00178	0.00178	CcSEcCtD
Mechlorethamine—Pruritus—Erlotinib—kidney cancer	0.00177	0.00178	CcSEcCtD
Mechlorethamine—Agranulocytosis—Capecitabine—kidney cancer	0.00175	0.00176	CcSEcCtD
Mechlorethamine—Anorexia—Vincristine—kidney cancer	0.00175	0.00176	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Gemcitabine—kidney cancer	0.00174	0.00175	CcSEcCtD
Mechlorethamine—Infection—Gemcitabine—kidney cancer	0.00173	0.00174	CcSEcCtD
Mechlorethamine—Diarrhoea—Erlotinib—kidney cancer	0.00171	0.00172	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Gemcitabine—kidney cancer	0.0017	0.00171	CcSEcCtD
Mechlorethamine—Haemoglobin—Capecitabine—kidney cancer	0.00169	0.0017	CcSEcCtD
Mechlorethamine—Skin disorder—Gemcitabine—kidney cancer	0.00169	0.0017	CcSEcCtD
Mechlorethamine—Haemorrhage—Capecitabine—kidney cancer	0.00168	0.00169	CcSEcCtD
Mechlorethamine—Hypersensitivity—Sorafenib—kidney cancer	0.00166	0.00167	CcSEcCtD
Mechlorethamine—Anorexia—Gemcitabine—kidney cancer	0.00166	0.00167	CcSEcCtD
Mechlorethamine—Vomiting—Vinblastine—kidney cancer	0.00166	0.00166	CcSEcCtD
Mechlorethamine—Vomiting—Everolimus—kidney cancer	0.00165	0.00166	CcSEcCtD
Mechlorethamine—Dermatitis bullous—Doxorubicin—kidney cancer	0.00164	0.00165	CcSEcCtD
Mechlorethamine—Rash—Everolimus—kidney cancer	0.00164	0.00164	CcSEcCtD
Mechlorethamine—Dermatitis—Everolimus—kidney cancer	0.00164	0.00164	CcSEcCtD
Mechlorethamine—Vertigo—Paclitaxel—kidney cancer	0.0016	0.00161	CcSEcCtD
Mechlorethamine—Leukopenia—Paclitaxel—kidney cancer	0.0016	0.0016	CcSEcCtD
Mechlorethamine—Hypersensitivity—Sunitinib—kidney cancer	0.0016	0.0016	CcSEcCtD
Mechlorethamine—Decreased appetite—Vincristine—kidney cancer	0.0016	0.0016	CcSEcCtD
Mechlorethamine—Pruritus—Sorafenib—kidney cancer	0.0016	0.0016	CcSEcCtD
Mechlorethamine—Vomiting—Erlotinib—kidney cancer	0.00159	0.0016	CcSEcCtD
Mechlorethamine—Erythema multiforme—Capecitabine—kidney cancer	0.00159	0.0016	CcSEcCtD
Mechlorethamine—Rash—Erlotinib—kidney cancer	0.00158	0.00159	CcSEcCtD
Mechlorethamine—Dermatitis—Erlotinib—kidney cancer	0.00158	0.00158	CcSEcCtD
Mechlorethamine—Tinnitus—Capecitabine—kidney cancer	0.00157	0.00158	CcSEcCtD
Mechlorethamine—Nausea—Vinblastine—kidney cancer	0.00155	0.00155	CcSEcCtD
Mechlorethamine—Nausea—Everolimus—kidney cancer	0.00154	0.00155	CcSEcCtD
Mechlorethamine—Diarrhoea—Sorafenib—kidney cancer	0.00154	0.00155	CcSEcCtD
Mechlorethamine—Pruritus—Sunitinib—kidney cancer	0.00153	0.00154	CcSEcCtD
Mechlorethamine—Decreased appetite—Gemcitabine—kidney cancer	0.00151	0.00152	CcSEcCtD
Mechlorethamine—Hypersensitivity—Dactinomycin—kidney cancer	0.00151	0.00152	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00151	0.00152	CcSEcCtD
Mechlorethamine—Nausea—Erlotinib—kidney cancer	0.00149	0.00149	CcSEcCtD
Mechlorethamine—Alopecia—Capecitabine—kidney cancer	0.00149	0.00149	CcSEcCtD
Mechlorethamine—Diarrhoea—Sunitinib—kidney cancer	0.00148	0.00149	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Paclitaxel—kidney cancer	0.00146	0.00146	CcSEcCtD
Mechlorethamine—Infection—Paclitaxel—kidney cancer	0.00145	0.00145	CcSEcCtD
Mechlorethamine—Vomiting—Sorafenib—kidney cancer	0.00143	0.00144	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Paclitaxel—kidney cancer	0.00143	0.00143	CcSEcCtD
Mechlorethamine—Rash—Sorafenib—kidney cancer	0.00142	0.00143	CcSEcCtD
Mechlorethamine—Dermatitis—Sorafenib—kidney cancer	0.00142	0.00143	CcSEcCtD
Mechlorethamine—Skin disorder—Paclitaxel—kidney cancer	0.00142	0.00142	CcSEcCtD
Mechlorethamine—Diarrhoea—Dactinomycin—kidney cancer	0.00141	0.00141	CcSEcCtD
Mechlorethamine—Anorexia—Paclitaxel—kidney cancer	0.00139	0.00139	CcSEcCtD
Mechlorethamine—Vomiting—Sunitinib—kidney cancer	0.00138	0.00138	CcSEcCtD
Mechlorethamine—Rash—Sunitinib—kidney cancer	0.00137	0.00137	CcSEcCtD
Mechlorethamine—Dermatitis—Sunitinib—kidney cancer	0.00137	0.00137	CcSEcCtD
Mechlorethamine—Hypersensitivity—Vincristine—kidney cancer	0.00135	0.00136	CcSEcCtD
Mechlorethamine—Nausea—Sorafenib—kidney cancer	0.00134	0.00134	CcSEcCtD
Mechlorethamine—Vertigo—Capecitabine—kidney cancer	0.00132	0.00132	CcSEcCtD
Mechlorethamine—Leukopenia—Capecitabine—kidney cancer	0.00131	0.00132	CcSEcCtD
Mechlorethamine—Vomiting—Dactinomycin—kidney cancer	0.00131	0.00131	CcSEcCtD
Mechlorethamine—Rash—Dactinomycin—kidney cancer	0.00129	0.0013	CcSEcCtD
Mechlorethamine—Nausea—Sunitinib—kidney cancer	0.00129	0.00129	CcSEcCtD
Mechlorethamine—Pancytopenia—Doxorubicin—kidney cancer	0.00129	0.00129	CcSEcCtD
Mechlorethamine—Decreased appetite—Paclitaxel—kidney cancer	0.00127	0.00127	CcSEcCtD
Mechlorethamine—Diarrhoea—Vincristine—kidney cancer	0.00126	0.00126	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00124	0.00124	CcSEcCtD
Mechlorethamine—Pruritus—Gemcitabine—kidney cancer	0.00123	0.00124	CcSEcCtD
Mechlorethamine—Nausea—Dactinomycin—kidney cancer	0.00122	0.00122	CcSEcCtD
Mechlorethamine—Diarrhoea—Gemcitabine—kidney cancer	0.00119	0.0012	CcSEcCtD
Mechlorethamine—Infection—Capecitabine—kidney cancer	0.00119	0.00119	CcSEcCtD
Mechlorethamine—Jaundice—Doxorubicin—kidney cancer	0.00118	0.00118	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Capecitabine—kidney cancer	0.00117	0.00118	CcSEcCtD
Mechlorethamine—Vomiting—Vincristine—kidney cancer	0.00117	0.00117	CcSEcCtD
Mechlorethamine—Skin disorder—Capecitabine—kidney cancer	0.00116	0.00117	CcSEcCtD
Mechlorethamine—Rash—Vincristine—kidney cancer	0.00116	0.00116	CcSEcCtD
Mechlorethamine—Dermatitis—Vincristine—kidney cancer	0.00116	0.00116	CcSEcCtD
Mechlorethamine—Anorexia—Capecitabine—kidney cancer	0.00114	0.00114	CcSEcCtD
Mechlorethamine—Agranulocytosis—Doxorubicin—kidney cancer	0.00113	0.00113	CcSEcCtD
Mechlorethamine—Vomiting—Gemcitabine—kidney cancer	0.00111	0.00111	CcSEcCtD
Mechlorethamine—Rash—Gemcitabine—kidney cancer	0.0011	0.0011	CcSEcCtD
Mechlorethamine—Dermatitis—Gemcitabine—kidney cancer	0.0011	0.0011	CcSEcCtD
Mechlorethamine—Haemoglobin—Doxorubicin—kidney cancer	0.00109	0.00109	CcSEcCtD
Mechlorethamine—Nausea—Vincristine—kidney cancer	0.00109	0.00109	CcSEcCtD
Mechlorethamine—Haemorrhage—Doxorubicin—kidney cancer	0.00109	0.00109	CcSEcCtD
Mechlorethamine—Hypersensitivity—Paclitaxel—kidney cancer	0.00107	0.00108	CcSEcCtD
Mechlorethamine—Decreased appetite—Capecitabine—kidney cancer	0.00104	0.00104	CcSEcCtD
Mechlorethamine—Nausea—Gemcitabine—kidney cancer	0.00103	0.00104	CcSEcCtD
Mechlorethamine—Pruritus—Paclitaxel—kidney cancer	0.00103	0.00104	CcSEcCtD
Mechlorethamine—Erythema multiforme—Doxorubicin—kidney cancer	0.00103	0.00103	CcSEcCtD
Mechlorethamine—Tinnitus—Doxorubicin—kidney cancer	0.00101	0.00102	CcSEcCtD
Mechlorethamine—Diarrhoea—Paclitaxel—kidney cancer	0.000997	0.001	CcSEcCtD
Mechlorethamine—Alopecia—Doxorubicin—kidney cancer	0.000959	0.000963	CcSEcCtD
Mechlorethamine—Vomiting—Paclitaxel—kidney cancer	0.000927	0.00093	CcSEcCtD
Mechlorethamine—Rash—Paclitaxel—kidney cancer	0.000919	0.000922	CcSEcCtD
Mechlorethamine—Dermatitis—Paclitaxel—kidney cancer	0.000918	0.000922	CcSEcCtD
Mechlorethamine—Hypersensitivity—Capecitabine—kidney cancer	0.000881	0.000885	CcSEcCtD
Mechlorethamine—Nausea—Paclitaxel—kidney cancer	0.000866	0.000869	CcSEcCtD
Mechlorethamine—Vertigo—Doxorubicin—kidney cancer	0.000849	0.000852	CcSEcCtD
Mechlorethamine—Pruritus—Capecitabine—kidney cancer	0.000846	0.000849	CcSEcCtD
Mechlorethamine—Leukopenia—Doxorubicin—kidney cancer	0.000846	0.000849	CcSEcCtD
Mechlorethamine—Diarrhoea—Capecitabine—kidney cancer	0.000818	0.000821	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000799	0.000802	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000771	0.000774	CcSEcCtD
Mechlorethamine—Infection—Doxorubicin—kidney cancer	0.000766	0.000769	CcSEcCtD
Mechlorethamine—Vomiting—Capecitabine—kidney cancer	0.00076	0.000763	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Doxorubicin—kidney cancer	0.000755	0.000758	CcSEcCtD
Mechlorethamine—Rash—Capecitabine—kidney cancer	0.000754	0.000757	CcSEcCtD
Mechlorethamine—Dermatitis—Capecitabine—kidney cancer	0.000753	0.000756	CcSEcCtD
Mechlorethamine—Skin disorder—Doxorubicin—kidney cancer	0.000749	0.000752	CcSEcCtD
Mechlorethamine—Anorexia—Doxorubicin—kidney cancer	0.000735	0.000738	CcSEcCtD
Mechlorethamine—Nausea—Capecitabine—kidney cancer	0.00071	0.000713	CcSEcCtD
Mechlorethamine—Decreased appetite—Doxorubicin—kidney cancer	0.00067	0.000673	CcSEcCtD
Mechlorethamine—Hypersensitivity—Doxorubicin—kidney cancer	0.000568	0.00057	CcSEcCtD
Mechlorethamine—Pruritus—Doxorubicin—kidney cancer	0.000545	0.000548	CcSEcCtD
Mechlorethamine—Diarrhoea—Doxorubicin—kidney cancer	0.000527	0.000529	CcSEcCtD
Mechlorethamine—Vomiting—Doxorubicin—kidney cancer	0.00049	0.000492	CcSEcCtD
Mechlorethamine—Rash—Doxorubicin—kidney cancer	0.000486	0.000488	CcSEcCtD
Mechlorethamine—Dermatitis—Doxorubicin—kidney cancer	0.000486	0.000487	CcSEcCtD
Mechlorethamine—Nausea—Doxorubicin—kidney cancer	0.000458	0.00046	CcSEcCtD
